Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Pyrin and HIN Domain Family, Member 1 (PYHIN1) Peptide

PYHIN1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN982511

Quick Overview for Pyrin and HIN Domain Family, Member 1 (PYHIN1) Peptide (ABIN982511)

Target

PYHIN1 (Pyrin and HIN Domain Family, Member 1 (PYHIN1))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-PYHIN1 antibody (Catalog #: ARP50876_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    PYHIN1 (Pyrin and HIN Domain Family, Member 1 (PYHIN1))

    Background

    PYHIN1 belongs to the HIN-200 family. This protein is major mediator of the tumor suppressor activity of IFN in breast cancer cells. It promotes ubiquitination and subsequent degradation of MDM2, which leads to p53/TP53 stabilization, and HDAC1, which in turn enhances maspin expression, and impairs invasive activity of cancer cells.

    Alias Symbols: IFIX, MGC23885, RP11-520H16.1

    Protein Size: 452

    Molecular Weight

    51 kDa

    Gene ID

    149628

    NCBI Accession

    NM_198930, NP_945148
You are here:
Chat with us!